During the past decade, Sjællands Universitetshospital, Roskilde; Øjenafdelingen conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Neovascular Age-Related Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" in a lesser frequency.

Most popular intervention types in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are "Drug" (7 trials), "Other" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Lampalizumab" (2 trials) and "Port Delivery System with ranibizumab (PDS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Sjællands Universitetshospital, Roskilde; Øjenafdelingen". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sjællands Universitetshospital, Roskilde; Øjenafdelingen, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sjællands Universitetshospital, Roskilde; Øjenafdelingen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".